日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Pathophysiological Significance of Dual Inhibition of IL-17A and IL-17F in Psoriatic Arthritis and Axial Spondyloarthritis

IL-17A 和 IL-17F 双重抑制在银屑病关节炎和中轴型脊柱关节炎中的病理生理意义

Katsouli, Olga; Lainis, Vasileios; Goules, Andreas V; Vlachoyiannopoulos, Panayiotis G

Th17 cells with regulatory phenotype are the main IL-17F and IL-26 producers in palmoplantar pustulosis.

具有调节表型的 Th17 细胞是掌跖脓疱病中 IL-17F 和 IL-26 的主要产生细胞。

Do Tran H, Bogle Rachael, Zhang Haihan, Xing Xianying, Gharaee-Kermani Mehrnaz, Raducu Madalina, Fox Jennifer, Jiang Rundong, Plazyo Olesya, Harms Paul W, Nakamura Mio, Xing Enze, Gilliet Michel, Billi Allison C, Kahlenberg J Michelle, Modlin Robert L, Uluckan Ozge, Tsoi Lam C, Gudjonsson Johann E

Serum IL-17F as a biomarker of infection-independent cirrhosis progression

血清IL-17F作为感染非依赖性肝硬化进展的生物标志物

Konstantis, Georgios; Passenberg, Moritz; Guntlisbergen, Clara; Schütte, Andreas; Jung, Björn; Nuruzade, Nargiz; Seltsam, Florian; Hoyer, Dieter P; Best, Jan; Willuweit, Katharina; Schmidt, Hartmut H; Guckenbiehl, Sabrina; Rashidi-Alavijeh, Jassin

Human spinal enthesis comparative biology of IL-17F and IL-17A reveals greater T-cell IL-17F induction and IL-23 regulation

人类脊髓附着点IL-17F和IL-17A的比较生物学研究揭示了T细胞IL-17F诱导增强和IL-23调控增强。

McDermott, Nicole; Altaie, Ala; Macleod, Tom; Bridgewood, Charlie; Loughenbury, Peter; Dunsmuir, Robert; Khan, Almas; Borse, Vishal; Rao, Abhay; Manghera, Avneet; Shaw, Stevan; McGonagle, Dennis

Streptococcus gallolyticus supernatant induces M2 macrophage polarization and activates IL-17 F signaling in colorectal tumorigenesis

溶血链球菌上清液诱导M2巨噬细胞极化并激活IL-17F信号通路,促进结直肠肿瘤发生

Jiaqi Wang # ,Yan Zhang # ,Duo Luo # ,Jing Xu ,Xin Nie ,Chen Huang ,Hailan Zhao ,Minzheng Zhu ,Xue Guo ,Yong Zhang ,Wenjing Qiu ,Haoming Xu ,Yuqiang Nie ,Youlian Zhou

Assessing the association of IL-17A and IL-17F polymorphisms with osteoarthritis risk: a systematic review and meta-analysis

评估IL-17A和IL-17F多态性与骨关节炎风险的关联:系统评价和荟萃分析

Xu, Ran; Liu, Xin; Zhou, Fan; Liu, Jie; Bai, Dunyao

Bimekizumab: The First FDA-Approved Dual IL-17A/IL-17F Inhibitor for Plaque Psoriasis - A Comprehensive Literature Review

Bimekizumab:首个获FDA批准用于治疗斑块状银屑病的双重IL-17A/IL-17F抑制剂——综合文献综述

Al Alshaikh, Sukainah Ahmed; Almarhoon, Zahra Mohammad; Momattin, Hisham; Aleid, Mahdi; Almousa, Zahra H; Alqaisum, Ali Kamal; Mobarki, Fatimah Ismail; Almakki, Sarah Aon; Alturfi, Hamzah; Almajed, Kouther Jamil

Sonelokimab, an IL-17A/IL-17F-inhibiting nanobody for active psoriatic arthritis: a randomized, placebo-controlled phase 2 trial

Sonelokimab,一种用于治疗活动性银屑病关节炎的IL-17A/IL-17F抑制纳米抗体:一项随机、安慰剂对照的II期试验

McInnes, Iain B; Coates, Laura C; Mease, Philip J; Ogdie, Alexis; Kavanaugh, Arthur; Eder, Lihi; Schett, Georg; Kivitz, Alan; McGonagle, Dennis; Brennan, Nuala; Godwood, Alex; Cullen, Eva; Reich, Kristian; Ritchlin, Christopher T; Merola, Joseph F

Circulating IL-17F, but not IL-17A, is elevated in severe COVID-19 and leads to an ERK1/2 and p38 MAPK-dependent increase in ICAM-1 cell surface expression and neutrophil adhesion on endothelial cells

重症 COVID-19 患者循环中的 IL-17F 水平升高,而 IL-17A 水平未升高,IL-17F 可导致 ERK1/2 和 p38 MAPK 依赖性的 ICAM-1 细胞表面表达增加,并促进中性粒细胞黏附于内皮细胞。

Jérôme Bédard-Matteau ,Antoine Soulé ,Katelyn Yixiu Liu ,Lyvia Fourcade ,Douglas D Fraser ,Amin Emad ,Simon Rousseau

Amelioration of Systemic Amyloidosis by Blocking IL-17A and Not by IL-17F, and Arteriosclerosis by Blocking Both IL-17A and IL-17F in an Inflammatory Skin Mouse Model

在炎症性皮肤小鼠模型中,阻断IL-17A而非IL-17F可改善全身性淀粉样变性,同时阻断IL-17A和IL-17F可改善动脉硬化。

Nakanishi, Takehisa; Iida, Shohei; Ichishi, Masako; Kondo, Makoto; Nishimura, Mai; Ichikawa, Ayaka; Matsushima, Yoshiaki; Iwakura, Yoichiro; Watanabe, Masatoshi; Yamanaka, Keiichi